bioAffinity Technologies, Inc. - BIAF

Sector: Healthcare · Industry: Diagnostics & Research
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2025 · Q2 2025
Value (USD)
Total reported value ($000)
$814K
QoQ value delta ($000)
+$716K (+730.61%)
Implied price effect (QoQ)
+902.93%
Shares
Total shares
300,065
QoQ shares delta
-62,251 (-17.18%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BIAF)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2025)

Top 25 only Full list
Early Q2 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
SABBY MANAGEMENT, LLC 718 242,757 0.83%
Scientech Research LLC 49 16,583 0.02%
VANGUARD GROUP INC 30 10,429 0.0%
Tower Research Capital LLC (TRC) 7 2,499 0.0%
IFP Advisors, Inc 6 25,833 0.0%
BANK OF AMERICA CORP /DE/ 4 1,684 0.0%
FMR LLC 0 26 0.0%
CITIGROUP INC 0 75 0.0%
MORGAN STANLEY 0 3 0.0%
UBS Group AG 0 143 0.0%
Larson Financial Group LLC 0 33 0.0%